An in vivo assay demonstrated that SOX9-promoted peritoneal metastasis was blocked by S100P knockdown, indicating that up-regulation of S100P expression at least partially accounts for the function of SOX9 in promotion of tumor progression in vivo. The gene discussed is S100P; the disease is neoplasm.